Role of family history and 5-HTTLPR polymorphism in female seasonal affective disorder patients with and without premenstrual dysphoric disorder

European Neuropsychopharmacology

Volumn 12, Issue 2, 2002, Pages 129-134

  Praschak Rieder, Nicole ^a   Willeit, Matth�us ^a   Winkler, Dietmar ^a   Neumeister, Alexander ^a,b   Hilger, Eva ^a   Zill, Peter ^c   Hornik, Kurt ^a   Stastny, J�rgen ^a   Thierry, Nikolaus ^a   Ackenheil, Manfred ^c   Bondy, Brigitta ^c   Kasper, Siegfried ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

5 HTTLPR; Family history; Genetics; Premenstrual dysphoric disorder; Seasonal affective disorder

Indexed keywords

DNA; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; AFFECTIVE NEUROSIS; ALLELE; ARTICLE; BRAIN DYSFUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PROMOTER REGION; RELATIVE; RISK FACTOR;

ADULT; CARRIER PROTEINS; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; ODDS RATIO; POLYMORPHISM, GENETIC; PREMENSTRUAL SYNDROME; PROMOTER REGIONS (GENETICS); REGRESSION ANALYSIS; SEASONAL AFFECTIVE DISORDER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 0036177524     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(01)00146-8     Document Type: Article

References (53)

1. Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome
2. Nongenomic steroidal modulation of high-affinity serotonin transport
3. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder
4. The premenstrual syndrome: a twin study
5. Incidence of the premenstrual syndrome in twins
6. Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder
7. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review
8. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder
9. Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder
10. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets
11. Allelic variation of human serotonin transporter gene expression
12. Gender differences in the heritability of seasonal mood change
13. Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?
14. Seasonal affective disorder and serotonin-related polymorphisms
15. Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controls
16. Jahreszeit und Befindlichkeit in der Allgemeinbevölkerung. Eine Mehrebenenuntersuchung zur Epidemiologie, Biologie und therapeutischen Beeinflussbarkeit (Lichttherapie) saisonaler Befindlichkeitsschwankungen
17. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study
18. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression
19. Pathophysiology of seasonal affective disorder, a review
20. L-tryptophan augmentation of light therapy in patients with seasonal affective disorder
21. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy
22. Effects of the menstrual cycle on dependent variables in mood disorder research
23. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
24. Family psychiatric screening instruments for epidemiologic studies: pilot testing and validation
25. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter sites and mRNA levels
26. Seasonal changes in mood and behavior. The role of genetic factors
27. The prevalence of seasonal affective disorder is low among descendants of Icelandic emigrants in Canada
28. Seasonality of symptoms in women with late luteal phase dysphoric disorder
29. Acute tryptophan depletion aggravates premenstrual syndrome
30. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy
31. Seasonal affective disorder
32. Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder
33. Late luteal phase dysphoric disorder in young women
34. Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder
35. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy
36. Estrogen-serotonin interactions: implications for affective regulation
37. Platelet [3H] paroxetine and [3H] lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy
38. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria
39. Recognition of premenstrual dysphoric disorder and its treatment
40. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria
41. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment
42. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls
43. Genetic and environmental factors in premenstrual symptom reporting and its relationship to depression and a general neuroticism trait
44. Genetic and environmental variation in menstrual cycle: histories of two British twin samples
45. Food and mood: relationship between food, serotonin and affective disorders
46. Brief screening for family psychiatric history: the family history screen
47. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
48. Carbohydrate craving. Relationship between carbohydrate intake and disorders of mood